img

2008 ADAO Conference, Detroit

Share
Session I Introduction
8:30-8:40 Welcome
Linda Reinstein, ADAO Executive Director and Co-founder
8:40-8:50 Welcome
John C. Ruckdeschel, MD, president and CEO, Karmanos Cancer Institute
8:50-9:10 Opening Address: History of Asbestos Disease and Preventing Exposure – Prevention Is the Best Cure!
Richard Lemen, PhD, MSPH Assistant Surgeon General, USPHS (Ret.) ADAO Science Advisory Board Co-Chair
Session II Diagnosis and Treatment
Chair: Michael Harbut, MD, MPH, FCCP
Asbestos-Related Disease
9:10-9:30 Non-malignant Asbestos-Related Disease  
Michael R. Harbut, MD, MPH, FCCP Co-Director, National Center for Vermiculite and Asbestos-Related Cancers Karmanos Cancer Institute
9:30-9:50 Malignant Asbestos-Caused Cancer
John C. Ruckdeschel, MD, president and CEO, Karmanos Cancer Institute
9:50-10:10 Psycho-Social Impact of ARD
Rebecca J.W. Cline, PhD, Senior Scientist, Karmanos Cancer Institute, and Associate Professor of Camily Medicine and Public Health Sciences, Wayne State University
10:10-10:30 Patient Advocacy and Matrix of Care
Linda Reinstein, ADAO Executive Director and Co-Founder
10:30-10:50 Pleural Plaques eh? A Canadian Experience Dealing with Asbestos-exposed Workers
Warren Teel, MD, Consultant Physician Occupational Health Clinic for Ontario Workers, Sarnia-Lambton
11:10-11:40 Patients Q&A
11:40-12:10 ADAO Award Presentation
12:10-12:30 “Mesothelioma and the Asbestos Workers: Father, Spouse, Contemporary and Daughter. A Short Story of their Exposure and Disease”
Terry Lynch, Int’l Vice President, Political & Legislative Director/Health Hazard Administrator, Insulators Union
Session III North American Action on Asbestos
Chair: Arthur L. Frank, MD, PhD
1:30-1:50 Asbestos Disease in Sarnia Ontario: A Case Study Into a Canadian Blue-Collar CommunityLiving a Preventable Cancer Tragedy
Jim Brophy, PhD Executive Director, Occupational Health Clinic for Ontario Workers, Sarnia
1:50-2:10 CARD Clinic & Community Action in Libby
Brad Black, MD, Medical Director, Center for Asbestos Related Disease
2:10-2:30 EPA (NOA and Superfund Sites)
Aubrey Miller, MD, MPH, Senior Medical Officer & Toxicologist, Environmental Protection Agency
2:30-2:40 ADAO Product Testing Report
Paul Zygielbaum, ADAO Project Manager and Mesothelioma Patient
2:40-2:50 2008 Updated: Asbestos Under the Steps of the U.S. Capitol
John Thayer, Former U.S. Captiol Tunnel Worker Supervisor
Session IV Global Contamination and Advocacy
Chair: Laurie Kazan-Allen
3:15-3:30 Case Study: The Canadian Autoworkers’ Asbestos Campaign
Lyle Hargrove, Director of CAW Health and Safety Training Fund and Sari Sairanen, CAW National Health & Safety Director
3:30-3:45 U.S. Developments: Legal/Judicial
Barry Castleman, ScD, Environmental Consultant
3:45-4:00 Asbestos in Shipbreaking: A Deadly Reality in Bangladesh
Dr. Bishakha Ghose, Head, Department of Community Medicine BGC Trust Medical College Chandanaish Chittagong, Bangladesh
4:00–4:15 Trail of Tears: South African Communities at Risk from Environmental Exposures
Robert Jones, Environmental Researcher – Rhodes University
4:15-4:30 Global Panorama 2008
Laurie Kazan-Allen, International Ban Secretariat
4:30-5:00 General Conference Q&A
Concluding Session
5:00-5:20 Jordan Zevon, ADAO National Spokesperson and Musician
5:20-5:30 Linda Reinstein, Dr. John C. Ruckdeschel, Dr. Michael Harbut and Laurie Kazan-Allen